Somiaxon
Broad-spectrum antibiotic for severe bacterial infections including septicaemia, meningitis, and pneumonia.
WHO-GMP certified injectable & oral formulations trusted by 500+ healthcare professionals across India. Quality medicine, better outcomes.
Every batch tested for purity, potency and safety.
Health for All — our guiding philosophy and the driving force behind every medicine we develop.
Somisto Pharma VisionSomisto Pharma is a new global pharmaceutical company dedicated to developing cutting-edge healthcare solutions and advancing healthcare through innovative research and high-quality medicines. Headquartered in New Delhi, India, we specialise in active pharmaceutical ingredients, generics, branded formulations, and biosimilars.
Driven by the philosophy of "Health for All," we focus on safety, efficacy, and accessibility — delivering impactful treatments that make a real difference in global health.
Actively serving North India with a growing distribution network and a commitment to expanding our reach.
Known for deep scientific expertise, complex molecule development, and sustainable healthcare solutions.
Committed to environmental responsibility, social impact, and governance — with initiatives for access to medicines and sustainable manufacturing.
Founded in 2025 with a clear mission — to make high-quality healthcare accessible to all, guided by scientific innovation and ethical practices.
WHO-GMP certified injectable and oral formulations designed for superior therapeutic outcomes and patient safety.
Broad-spectrum antibiotic for severe bacterial infections including septicaemia, meningitis, and pneumonia.
Complete parenteral multivitamin supplement for patients on TPN or with documented vitamin deficiencies.
Extended-spectrum penicillin with beta-lactamase inhibitor for polymicrobial and nosocomial infections.
Active form of vitamin B12 for peripheral neuropathy, diabetic neuropathy, and megaloblastic anaemia.
Parenteral aminoglycoside for serious Gram-negative infections, including those resistant to gentamicin and tobramycin.
IV paracetamol infusion for management of pain and pyrexia in adults and children over 2 years.
Ultra-broad spectrum carbapenem for severe hospital-acquired infections and multi-drug resistant organisms.
Lyophilised powder for injection used in GERD, peptic ulcer disease and Zollinger-Ellison syndrome.
Potent antiemetic for prevention and treatment of chemotherapy-induced, radiotherapy-induced and post-operative nausea.
IV iron replacement for iron-deficiency anaemia in patients with chronic kidney disease and non-dialysis.
We combine cutting-edge science, rigorous quality standards, and a patient-first philosophy to deliver medicines that make a real difference.
WHO-GMP and ISO 9001:2015 certified. Every product meets stringent international quality standards from synthesis to packaging.
Our dedicated R&D team continuously innovates, developing novel formulations and improving existing products for better efficacy.
Over 500 healthcare professionals, hospitals and clinics across India trust our products for critical care and routine therapy.
Pharmacovigilance is at our core. We monitor every product post-market to ensure continued safety and effectiveness.
Real feedback from doctors and clinicians who rely on Somisto Pharma products every day.
Somisto Pharma's injectable range has been exceptional in our ICU. The sterility, potency and consistent quality of Somipenem and Somiaxon give us complete confidence in critical care situations.
I regularly prescribe Somimol and Somisetrem for post-operative management. The supply is reliable, the efficacy matches branded products, and the pricing makes it accessible for all my patients.
Somisucrose (Iron Sucrose) from Somisto has been a game-changer for my CKD patients. Excellent tolerability, consistent lot quality, and the team's responsiveness to queries is outstanding.
Yes. All our manufacturing facilities and products are fully WHO-GMP certified. We also hold ISO 9001:2015 certification and all our formulations are approved by the DCGI (Drug Controller General of India).
Our portfolio covers a wide range including antibiotics (cephalosporins, carbapenems, penicillins), analgesics/antipyretics, proton pump inhibitors, antiemetics, haematinics, neurological supplements and nutritional support — primarily as injectable formulations.
We welcome authorised distributors and stockists across all regions. Please reach out via our contact form or call our business development team. We'll guide you through our onboarding process, documentation requirements and territory allocation.
MOQ varies by product and packaging. For hospitals and institutional buyers, we offer flexible terms. Distributors typically have defined MOQs per SKU. Please contact our sales team with your requirements for a customised quotation.
Yes, we provide complimentary samples to registered medical practitioners and qualified institutional buyers for evaluation purposes. Requests can be submitted through our contact form or directly via our field medical representatives.
We maintain a validated cold-chain infrastructure from warehouse to last-mile delivery for products requiring 2–8°C storage. Our logistics partners are trained in pharmaceutical cold-chain management to ensure product integrity.
Our medical information team is available Monday to Saturday, 9AM–6PM to answer your product or regulatory queries.
Contact Our TeamReach out for product enquiries, distribution partnerships, or any other information. Our team responds within 24 hours.
363, 2nd Floor, Block AW,
Sanjay Gandhi Transport Nagar, Delhi - 42
Monday – Saturday: 9:00 AM – 6:00 PM